Chemoinformaics analysis of Methyl ganoderenate A
| Molecular Weight | 528.686 | nRot | 5 |
| Heavy Atom Molecular Weight | 484.334 | nRig | 26 |
| Exact Molecular Weight | 528.309 | nRing | 4 |
| Solubility: LogS | -4.468 | nHRing | 0 |
| Solubility: LogP | 2.971 | No. of Aliphatic Rings | 4 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 4 |
| Atoms Count | 82 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 38 | No. of Aromatic Carbocycles | 0 |
| nHetero | 7 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 2 |
| No. of Hydrogen atom | 44 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 31 | No. of Saturated Rings | 2 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 7 | No. of Arom Bond | 0 |
| nHA | 7 | APOL | 86.7229 |
| nHD | 2 | BPOL | 49.3491 |
| QED | 0.418 |
| Synth | 5.228 |
| Natural Product Likeliness | 2.95 |
| NR-PPAR-gamma | 0.29 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0.996 |
| Pgp-sub | 0.004 |
| HIA | 0.063 |
| CACO-2 | -5.102 |
| MDCK | 0.0000176 |
| BBB | 0.98 |
| PPB | 0.772259 |
| VDSS | 0.379 |
| FU | 0.167083 |
| CYP1A2-inh | 0.004 |
| CYP1A2-sub | 0.72 |
| CYP2c19-inh | 0.11 |
| CYP2c19-sub | 0.952 |
| CYP2c9-inh | 0.232 |
| CYP2c9-sub | 0.301 |
| CYP2d6-inh | 0.002 |
| CYP2d6-sub | 0.324 |
| CYP3a4-inh | 0.617 |
| CYP3a4-sub | 0.554 |
| CL | 14.047 |
| T12 | 0.366 |
| hERG | 0.003 |
| Ames | 0.021 |
| ROA | 0.654 |
| SkinSen | 0.029 |
| Carcinogencity | 0.134 |
| EI | 0.011 |
| Respiratory | 0.846 |
| NR-Aromatase | 0.361 |
| Antiviral | Yes |
| Prediction | 0.827393 |